Company Presentation
Leman Biotech Lausanne SA
| Country: | Switzerland |
| Category: | Emerging Biotech Company |
| Room: | Singapore |
| Date: | 23.04.2024 |
| Time: | 15:45 – 16:00 |
| Website: | https://www.lemanbio.com/en/home |
| Speaker: | Karthik Sathiyanadan, Director, Translational Research |
Company profile
Leman Biotech SA, a clinical-stage EPFL spin-off co-founded by Prof. Li Tang, focuses on developing novel metabolic cancer immunotherapies. Headquartered in Shenzhen, China, its R&D pipelines include metabolism-enhanced CAR-T cell therapy and biomacromolecule drugs. The company recently initiated IIT clinical trials for its innovative metabolically armed CAR-T therapy. With US$18M in angel financing, Leman Biotech is well-positioned to expand the clinical development of its pipeline.
